Predicting the response to ECT.

[1]  M. Kitada.  Genetic polymorphism of cytochrome P450 enzymes in Asian populations: focus on CYP2D6. , 2003, International journal of clinical pharmacology research.

[2]  B. Carroll.  The Dexamethasone Suppression Test for Melancholia , 1982, British Journal of Psychiatry.

[3]  R. Kahn,et al.  Relation of electroencephalographic delta activity to behavioral response in electroshock; quantitative serial studies. , 1957, A.M.A. archives of neurology and psychiatry.

[4]  John R. Geddes,et al.  Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis , 2003, The Lancet.

[5]  H. Sackeim,et al.  Resistance to antidepressant medications and short-term clinical response to ECT. , 1996, The American journal of psychiatry.

[6]  A. Rush,et al.  Delta sleep EEG in depressed adolescent females and healthy controls. , 2001, Journal of affective disorders.

[7]  A. Rush,et al.  Ultradian rhythms and temporal coherence in sleep EEG in depressed children and adolescents , 2000, Biological Psychiatry.

[8]  M. Fink,et al.  Comparative study of chlorpromazine and insulin coma in therapy of psychosis. , 1958, Journal of the American Medical Association.

[9]  R. Baldessarini,et al.  The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Commentary and review. , 1985, Archives of general psychiatry.

[10]  P. Mulder,et al.  Effect of Antidepressant Medication Resistance on Short-term Response to Electroconvulsive Therapy , 2004, Journal of clinical psychopharmacology.

[11]  I. Cascorbi.  Pharmacogenetics of cytochrome P4502D6: genetic background and clinical implication , 2003, European journal of clinical investigation.

[12]  H. Sackeim,et al.  Convulsive therapy in schizophrenia? , 1996, Schizophrenia bulletin.

[13]  A. Zwinderman,et al.  Predictors for the efficacy of electroconvulsive therapy: chart review of a naturalistic study. , 2005, The Journal of clinical psychiatry.